3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Ovarian Neoplasms
5
Hematologic Neoplasms
5
Neoplasms
4
Prostatic Neoplasms
2
Multiple Myeloma
2
Lung Neoplasms
2
Hematopoietic and Lymphatic System Neoplasm
2
Fallopian Tube Neoplasms
2
Endometrial Neoplasms
2
Breast Neoplasms
2
Weight Cycling
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Triple Negative Breast Neoplasms
1
Tobacco Use Disorder
1
Tobacco Use Cessation
1
Substance-Related Disorders
1
Smoldering Multiple Myeloma
1
Smoking Cessation
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Obesity-Related Malignant Neoplasm
1
Neoplasm Metastasis
1
Motor Activity
1
Mental Disorders
1
Insulin Resistance
1
Hematopoietic and Lymphoid System Neoplasm
1
Head and Neck Neoplasms
1
Head and Neck Carcinoma
1
Genital Neoplasms, Female
1
Interventions
Metformin
21
Inositol
14
Letrozole
9
Exercise
5
Surveys and Questionnaires
4
Clomiphene
4
Tablets
3
Estradiol
3
semaglutide
2
maltodextrin
2
drospirenone and ethinyl estradiol combination
2
Spironolactone
2
Progesterone
2
Ethinyl Estradiol
2
Diet Therapy
2
Contraceptives, Oral, Combined
2
Caloric Restriction
2
Acupuncture Therapy
2
mirabegron
1
etonogestrel
1
drospirenone
1
dapagliflozin
1
cetrorelix
1
Walking
1
Tirzepatide
1
Thyroxine
1
Thioctic Acid
1
Tamoxifen
1
Sodium-Glucose Transporter 2 Inhibitors
1
Sex Characteristics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Polycystic Ovary Syndrome
×
Behavior Therapy
×
1 year
×
Clear all
NCT06545721
2025-12-03
WHIP
Peking Union Medical College Hospital
Phase NA
Recruiting
425 enrolled